Suppr超能文献

维持目标腹部灌注压能否降低感染性休克患者的肾损伤?一项随机、对照、开放标签研究。

Does Maintaining a Targeted Abdominal Perfusion Pressure Reduce Renal Damage in Patients with Septic Shock?: A Randomized, Controlled, and Open-label Study.

作者信息

Özkarakaş Hüseyin, Tekgül Zeki Tuncel, Arslan Murat, Bilgin Mehmet Uğur, Eker Hazal Ezgi, Okur Onur, Çalık Bülent

机构信息

Clinic of Intensive Care, University of Health Sciences Türkiye, İzmir Bozyaka Trainig and Research Hospital, İzmir, Türkiye

Clinic of Anesthesiology and Reanimation, Helios Klinikum Schleswig, Teaching Hospital for the University of Kiel, Kiel, Germany

出版信息

Balkan Med J. 2023 Oct 20;40(6):415-421. doi: 10.4274/balkanmedj.galenos.2023.2023-5-9. Epub 2023 Sep 18.

Abstract

BACKGROUND

Increased intra-abdominal pressure (IAP) in patients admitted to the intensive care unit leads to reduced abdominal perfusion pressure (APP), causing circulatory insufficiency and organ failure.

AIMS

To investigate the effect of maintaining a targeted APP on renal injury and the effect of increased IAP on the mortality rate in patients with septic shock.

STUDY DESIGN

Randomized, controlled, open-label study.

METHODS

A total of 72 patients were randomly divided into two groups (MAP65 or APP60). The MAP target for patients in the MAP65 group (n = 36) was 65 mmHg according to the Surviving Sepsis Guidelines. In the APP60 group (n = 36), the target APP was set to > 60 mmHg. The glomerular filtration rate (GFR), inotrope consumption, and IAP were recorded daily. The need for renal replacement therapy, decrease in GFR, and 30- and 90-day mortality rates were compared between the two groups.

RESULTS

In both the groups, the IAP was statistically similar ( = 0.458). The decreased in GFR was similar in both groups during the first 2 days. From day 3, there was a more statistically significant rapid decline in GFR in the MAP65 group than in the APP60 group. The GFR p-values on the 3, 4, and 5 days were 0.040, 0.043, and 0.032, respectively. Eight patients (22.2%) in the MAP65 group and three patients (8.3%) in the APP group required renal replacement therapy ( = 0.101). The 30-day mortality rates in the MAP65 and APP60 groups were 61.1%, and 47.7%, respectively ( = 0.237). The 90-day mortality rates in the MAP65 and APP60 groups were 66.7% and 66.7%, respectively ( = 1).

CONCLUSION

Setting an APP target limited the reduction in GFR. The mortality rates were similar in the two groups and there was no difference in the rate of end-stage renal failure between the groups.

摘要

背景

重症监护病房患者腹内压(IAP)升高会导致腹腔灌注压(APP)降低,进而引起循环功能不全和器官衰竭。

目的

探讨维持目标性APP对肾损伤的影响以及IAP升高对感染性休克患者死亡率的影响。

研究设计

随机、对照、开放标签研究。

方法

72例患者被随机分为两组(MAP65或APP60)。根据《拯救脓毒症指南》,MAP65组(n = 36)患者的MAP目标为65 mmHg。在APP60组(n = 36)中,目标APP设定为> 60 mmHg。每天记录肾小球滤过率(GFR)、血管活性药物用量和IAP。比较两组患者肾脏替代治疗的需求、GFR的下降情况以及30天和90天死亡率。

结果

两组患者的IAP在统计学上相似(P = 0.458)。两组患者在前2天GFR的下降情况相似。从第3天起,MAP65组GFR的下降速度在统计学上比APP60组更快。第3、4和5天的GFR p值分别为0.040、0.043和0.032。MAP65组有8例患者(22.2%)需要肾脏替代治疗,APP组有3例患者(8.3%)需要肾脏替代治疗(P = 0.101)。MAP65组和APP60组的30天死亡率分别为61.1%和47.7%(P = 0.237)。MAP65组和APP60组的90天死亡率分别为66.7%和66.7%(P = 1)。

结论

设定APP目标可限制GFR的降低。两组患者的死亡率相似,且两组患者终末期肾衰竭的发生率无差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验